Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
+647K
-
Total reported value, excl. options
-
$2.14B
-
Value change
-
+$7.06M
-
Put/Call ratio
-
0.8
-
Number of buys
-
88
-
Number of sells
-
-57
-
Price
-
$15.29
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2016
185 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q4 2016.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
of 162M outstanding shares and own 86.49% of the company stock.
Largest 10 shareholders include FMR LLC (19.7M shares), WELLINGTON MANAGEMENT GROUP LLP (18.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (14.5M shares), JANUS CAPITAL MANAGEMENT LLC (12.4M shares), VANGUARD GROUP INC (9.94M shares), ORBIMED ADVISORS LLC (7.24M shares), BlackRock Fund Advisors (6.45M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (5.95M shares), STATE STREET CORP (3.79M shares), and BlackRock Institutional Trust Company, N.A. (3.55M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.